Singapore markets closed
Straits Times Index
3,204.82 +2.01 (+0.06%) Nikkei
32,402.41 -168.62 (-0.52%) Hang Seng
18,057.45 +402.04 (+2.28%) FTSE 100
7,683.91 +5.29 (+0.07%) Bitcoin USD
26,581.69 +18.98 (+0.07%) CMC Crypto 200
565.87 -2.18 (-0.38%)
Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.14 |
| Open | 9.16 |
| Bid | 9.07 x 900 |
| Ask | 9.57 x 900 |
| Day's range | 8.90 - 9.52 |
| 52-week range | 8.90 - 31.55 |
| Volume | |
| Avg. volume | 1,529,646 |
| Market cap | 1.255B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.91 |
| Earnings date | 01 Nov 2023 - 06 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.75 |
Motley FoolIs Vir Biotechnology Stock a Buy?
Early in the coronavirus pandemic, Vir Biotechnology's (NASDAQ: VIR) stock rose -- literally and figuratively -- as it joined the list of biotechs looking for vaccines and therapies for the disease. Vir's shares are down by 47% this year alone. This could be a buying opportunity for long-term investors, but only if Vir has enough growth fuel left in the tank.
ZacksVir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of -19.83% and 71.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksBiotech Stock Roundup: BBIO, ARGX Soar on Study Results, APLS Down on Safety Issues
Regulatory and key pipeline updates from BridgeBio (BBIO) and argenx (ARGX) are in focus in the biotech sector.
© 2023 Yahoo. All rights reserved.
